Concepedia

Yoko Urasaki

YU

Statistics

Publications

5

Citations

105

H-Index

5

Active since

2004

Affiliations

Daiichi-Sankyo (Japan)(Current)

Daiichi Sankyo (Germany)

Yoko Urasaki is an author at Daiichi-Sankyo (Japan) specializing in pharmacology, drug disposition, and analytical chemistry.

Publications per year

2004–2021

5

Publications

5

Quantitative determination of pravastatin and R-416, its main metabolite in human plasma, by liquid chromatography–tandem mass spectrometry

Kiyoshi Kawabata, Naozumi Samata, Yoko Urasaki · Journal of Chromatography B · 2004 · 31 citations

, , +11

Enantioselective determination of azelnidipine in human plasma using liquid chromatography–tandem mass spectrometry

Kiyoshi Kawabata, Naozumi Samata, Yoko Urasaki et al. · Journal of Chromatography B · 2007 · 26 citations

, , +14

Stereoselective hydroxylation by CYP2C19 and oxidation by ADH4 in the<i>in vitro</i>metabolism of tivantinib

Yumi Nishiya, Daisuke Nakai, Yoko Urasaki et al. · Xenobiotica · 2016 · 20 citations

, , +17

Simultaneous determination of azelnidipine and two metabolites in human plasma using liquid chromatography-tandem mass spectrometry

Kohei Kawabata, Yoko Urasaki · Journal of Chromatography B · 2006 · 18 citations

, , +16

Metabolism, excretion, and pharmacokinetics of [<sup>14</sup>C]mirogabalin, a novel α<sub>2</sub>δ ligand, in healthy volunteers following oral administration

Naotoshi Yamamura, Jeanne Mendel-Harary, Karen Brown et al. · Xenobiotica · 2021 · 10 citations

, , +9

1–5 of 5